Publications by authors named "Molly Voss"

Claim this Profile
E
Exome Sequencing Enhances Screening for Familial Hypercholesterolemia Within a Multi-Site Healthcare System.
N Jewel Samadder, Mariah Schroeder, Molly M Voss, Fadi Shamoun, Iftikhar Kullo

Circ Genom Precis Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial.
Diego A S Toesca, William F Hartsell, Todd A DeWees, John H Chang, Brady S Laughlin, Molly M Voss

Int J Radiat Oncol Biol Phys· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-course hypofractionated proton beam therapy, incorporating F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.
Sujay Vora, Deanna Pafundi, Molly Voss, Matthew Buras, Jonathan Ashman

Lancet Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-Year Prostate-Specific Membrane Antigen Positron Emission Tomography-Based Outcomes of Spot-Scanning Proton Radiation Therapy for Localized Prostate Cancer: A Single Institution Experience.
Will Sperduto, Molly M Voss, Brady Laughlin, Diego A S Toesca, William W Wong

Adv Radiat Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter Multivendor Evaluation of Dose Volume Histogram Creation Consistencies for 8 Commercial Radiation Therapy Dosimetric Systems.
Gregory P Penoncello, Molly M Voss, Yu Gao, Levent Sensoy, Minsong Cao

Pract Radiat Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
Maria E Lozada, Ning Zhang, Weidong Jin, Nicha Wongjarupong, Ju Dong Yang, Molly M Voss

Am J Gastroenterol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3369 patients in the ARCAD database" Eur J Cancer. 2023 Jan;178:162-170.
Ofer Margalit, William S Harmsen, Einat Shacham-Shmueli, Molly M Voss, Ben Boursi

Eur J Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Identification of Copositivity Groups in Standard Series Patch Testing Through Hierarchical Clustering.
Yul W Yang, James A Yiannias, Molly M Voss, Matthew R Hall, Molly J Youssef

JAMA Dermatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience.
Brady S Laughlin, Sasha Ebrahimi, Molly M Voss, Samir H Patel, Robert L Foote

Adv Radiat Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating sex as a predictive marker for response to bevacizumab in metastatic colorectal carcinoma: Pooled analysis of 3,369 patients in the ARCAD database.
Ofer Margalit, William S Harmsen, Einat Shacham-Shmueli, Molly M Voss, Ben Boursi

Eur J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer.
Nathan Y Yu, Todd A DeWees, Molly M Voss, William G Breen, Jennifer S Chiang

Clin Lung Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary Analysis of a Phase II Trial of Stereotactic Body Radiation Therapy for Prostate Cancer With High-Risk Features After Radical Prostatectomy.
Brady S Laughlin, Molly M Voss, Diego A S Toesca, Thomas Daniels, Michael A Golafshar

Adv Radiat Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003.
Brady S Laughlin, Cameron S Thorpe, Todd A DeWees, Molly M Voss, John H Chang

Adv Radiat Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Versus Caregiver: Correlation and Differences in Pediatric Quality of Life Using a Prospective Registry in a Large-Volume, Multisite Practice.
Matthew R Buras, William G Breen, Nadia N Laack, Tamara Vern- Gross, Isabella Zaniletti, Molly M Voss

Int J Radiat Oncol Biol Phys· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer.
Justin D Anderson, Molly M Voss, Brady S Laughlin, Allison E Garda, Khaled Aziz

Int J Part Ther· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot/Phase II Trial of Hypofractionated Radiation Therapy to the Whole Breast Alone Before Breast Conserving Surgery.
Cameron S Thorpe, Todd A DeWees, Brady S Laughlin, Laura A Vallow, Dee Seneviratne, Molly M Voss

Adv Radiat Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis